360 Participants Needed

Mindfulness and CBT for Preventing Severe Mental Illness in Youth

(SWELL Trial)

Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Nova Scotia Health Authority
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The trial aims to test a new approach called maCBT to prevent severe mental illnesses like schizophrenia or mood disorders in young people. MaCBT, which stands for Multimodal Antecedent-focused Cognitive-behavioral Training, targets early warning signs such as anxiety, unusual sensory experiences, and mood swings. The goal is to help young individuals manage these symptoms early, potentially preventing severe mental illness later in life. This trial may suit young people aged 9-21 who have experienced anxiety, mood swings, or other early signs of mental health issues but have not been diagnosed with a severe mental illness. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could transform early mental health interventions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this intervention is safe for young people?

Research shows that Mindfulness and Cognitive Behavioral Therapy (CBT) are generally safe and well-tolerated. Studies have found that CBT helps people change unhelpful behaviors, improving mental health. When combined with CBT, mindfulness practices effectively prevent depression recurrence and enhance overall mental well-being.

Mindfulness-based cognitive therapies have increased life satisfaction and improved family relationships in teens. These therapies help individuals become more aware of their thoughts and feelings in the present moment, leading to better coping strategies.

While every treatment can have side effects, mindfulness and CBT are known for having few, if any, serious negative effects. They are widely used and accepted in mental health treatment, making them a safe option for young people.12345

Why are researchers excited about this trial?

Researchers are excited about maCBT because it offers a fresh approach to preventing severe mental illness in youth by integrating mindfulness with cognitive-behavioral techniques. Unlike traditional treatments that often focus on managing symptoms after they appear, maCBT aims to normalize unusual experiences and equip young people with proactive strategies to reduce their impact. This treatment is tailored to be age-appropriate, using visual materials and relatable language, making it particularly engaging for children and teens. Additionally, maCBT is delivered in a flexible format, with sessions that initially occur weekly and then shift to bi-weekly, allowing for personalized pacing and sustained support.

What evidence suggests that maCBT might be an effective treatment for preventing severe mental illness in youth?

Research has shown that Mindfulness and Acceptance-based Cognitive Behavioral Therapy (maCBT), which participants in this trial may receive, can help prevent serious mental health issues in young people. Studies have found that mindfulness-based therapy can improve life satisfaction and family relationships for teenagers. This therapy manages anxiety and unusual experiences by teaching self-management skills. maCBT helps young people understand and rethink unusual experiences, enabling them to develop coping strategies. These strategies aim to reduce the impact of early signs of mental health issues, such as anxiety and mood changes, before they worsen. Overall, maCBT appears promising in helping at-risk youth avoid severe mental health problems later in life.13678

Who Is on the Research Team?

Rudolf Uher - Department of Psychiatry ...

Rudolf Uher, MD

Principal Investigator

Nova Scotia Health Authority

Are You a Good Fit for This Trial?

This trial is for young individuals aged 9-21 who are part of the FORBOW study, showing early signs that may predict severe mental illness, like anxiety or mood swings. It's not for those with a severe mental illness diagnosis or who've had significant therapy recently.

Inclusion Criteria

I have experienced symptoms like hallucinations, mood swings, or severe anxiety.
I am a FORBOW participant aged between 9 and 21.

Exclusion Criteria

I have had more than 3 therapy sessions in the last year.
Diagnosis of severe mental illness (schizophrenia, other psychotic disorder, bipolar disorder, severe major depressive disorder)
Insufficient understanding of the English language to benefit from the intervention

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT) in 8 to 16 one-hour sessions, initially weekly, then bi-weekly.

8-16 weeks
8-16 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 4-6 months, 1, 2, 3, and 5 years post intervention.

5 years

Long-term follow-up

Annual follow-ups to assess long-term outcomes such as severe mental illness diagnosis and functioning.

10 years

What Are the Treatments Tested in This Trial?

Interventions

  • maCBT
Trial Overview The trial tests a new preventive intervention called maCBT aimed at improving self-management skills to prevent the development of severe mental illnesses in high-risk youths by addressing early symptoms.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: maCBTExperimental Treatment1 Intervention
Group II: ComparisonActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nova Scotia Health Authority

Lead Sponsor

Trials
302
Recruited
95,300+

Nova Scotia Health Research Foundation

Collaborator

Trials
15
Recruited
34,100+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+

Published Research Related to This Trial

Acceptance and Commitment Therapy (ACT) in a community camp setting significantly improved psychological flexibility and mindful awareness in children, as shown by self-report measures from the Avoidance and Fusion Questionnaire for Youth (AFQ-Y) and the Child Acceptance and Mindfulness Measure (CAMM).
The experimental group demonstrated substantial improvements compared to the control group, with significant differences in posttest scores, indicating that ACT is an effective and easily implemented intervention for enhancing mindfulness in children.
Neuro-Typical Children Outcomes from an Acceptance and Commitment Therapy Summer Camp.Enoch, MR., Dixon, MR.[2020]
The study explored the feasibility of an Acceptance and Commitment Therapy (ACT)-based prevention program for anxiety and depression among 48 high school students, showing that the program was acceptable and could be effectively implemented in a school setting.
While no statistically significant differences were found between the ACT intervention and usual classes, the effect sizes indicated potential benefits of the ACT program, suggesting it could be a promising approach for preventing anxiety and depression in young people and warrants further research with a larger sample.
Acceptance and commitment therapy universal prevention program for adolescents: a feasibility study.Burckhardt, R., Manicavasagar, V., Batterham, PJ., et al.[2020]
Mindfulness-Based Interventions (MBIs) showed small but significant treatment effects in youth, with a meta-analysis of 76 studies involving 6121 participants indicating an effect size of g=0.305 for pre-post designs and g=0.322 for controlled designs.
The effectiveness of MBIs appeared to increase over time, with follow-up assessments showing larger effects (g=0.462 for pre-post and g=0.402 for controlled designs), suggesting that the benefits of mindfulness practices may continue to grow after the intervention ends.
Mindfulness-based interventions with youth: A comprehensive meta-analysis of group-design studies.Klingbeil, DA., Renshaw, TL., Willenbrink, JB., et al.[2018]

Citations

Mindfulness and CBT for Preventing Severe Mental Illness ...The SWELL medical study, being run by Nova Scotia Health Authority, is evaluating whether maCBT will have tolerable side effects & efficacy for patients ...
Efficacy of mindfulness- and acceptance-based cognitive ...The primary outcome was somatic symptom severity. Secondary outcomes were degrees of depression and of anxiety, health anxiety, perceived health ...
Mindfulness- and acceptance-based cognitive ...Mindfulness-based cognitive therapy for hypochondriasis, or severe health anxiety: A pilot study. Journal of Anxiety Disorders, 24(8), 931–935. http://dx ...
Effectiveness of mindfulness based cognitive behavior ...Mindfulness based cognitive behaviour therapy improves life satisfaction, life orientation and family functioning of adolescents.
Mindfulness and Acceptance Based Therapy for ...The study proposes to explore acceptability of an adapted mindfulness and acceptance-based psychosocial intervention (acceptance and commitment therapy: ...
Cognitive–behavioral therapy for management of mental ...Cognitive–behavioral therapy (CBT) helps individuals to eliminate avoidant and safety-seeking behaviors that prevent self-correction of faulty beliefs.
Mindfulness-Based Cognitive Therapy in Clinical PracticeMBCT is a clinical intervention that integrates cognitive therapy with mindfulness practices to prevent depression relapses and improve mental health.
Effectiveness of Mindfulness-Based Cognitive Therapy ...Methods: The study involves an 8-week MBCT with a 10-month follow-up. Patients aged 20 to 65 years who meet the Diagnostic and Statistical ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security